Skip to main content
Log in

Zerebrotendinöse Xanthomatose—eine behandelbare Stoffwechselerkrankung

Leserbrief zum Beitrag von R. Heller et al. aus Nervenarzt (2002) 73:1160–1166

  • Leserbrief
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Sperhake JP, Matschke J, Orth U, Gal A, Püschel K (2000) Sudden death due to cerebrotendinous xanthomatosis confirmed by mutation analysis. Int J Legal Med 113:110–113

    Google Scholar 

  2. Ahmed MS, Afsar S, Hentati A et al. (1997) A novel mutation in the sterol 27-hydroxylase gene of a Pakistani family with autosomal recessive cerebrotendinous xanthomatosis. Neurology 48:258–260

    Google Scholar 

  3. Garuti R, Croce MA, Tiozzo R, Dotti MT, Federico A, Bertolini S, Calandra S (1997) Four novel mutations of sterol 27-hydroxylese gene in Italian patients with cerebrotendinous xanthomatosis. J Lipid Res 38:2322–2334

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. P. Sperhake.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sperhake, J.P., Matschke, J. Zerebrotendinöse Xanthomatose—eine behandelbare Stoffwechselerkrankung. Nervenarzt 75, 608 (2004). https://doi.org/10.1007/s00115-003-1500-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-003-1500-y

Navigation